|
Volumn 37, Issue 2, 2005, Pages 1224-1226
|
Infectious complications limit the outcome of liver transplantation in medical urgency code 2 patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
AZATHIOPRINE;
BASILIXIMAB;
CALCINEURIN INHIBITOR;
COLISTIN;
CYCLOSPORIN A;
DACLIZUMAB;
GANCICLOVIR;
GENTAMICIN;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PIPERACILLIN;
STEROID;
TACROLIMUS;
TAZOBACTAM;
THYMOCYTE ANTIBODY;
VALGANCICLOVIR;
ADULT;
AGED;
CANDIDA ALBICANS;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
ENDOCARDITIS;
FEMALE;
FIRST AID;
FOLLOW UP;
GENITAL HERPES;
HERPES SIMPLEX VIRUS;
HUMAN;
INFECTION RATE;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
MALE;
MYCOSIS;
PENICILLIN RESISTANCE;
PERIOPERATIVE PERIOD;
PNEUMONIA;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
SEPSIS;
STAPHYLOCOCCUS AUREUS;
TIME SERIES ANALYSIS;
TREATMENT OUTCOME;
VIRUS INFECTION;
|
EID: 17844366860
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.253 Document Type: Conference Paper |
Times cited : (5)
|
References (4)
|